Paracoccidioides

By /

Introduction

  • Paracoccidioides is a genus of thermally dimorphic fungi responsible for Paracoccidioidomycosis (PCM), a chronic systemic fungal infection primarily affecting individuals living in Latin America.
  • The disease is considered one of the most significant endemic mycoses in South and Central America.
  • The infection mainly involves the lungs but may disseminate to the skin, mucous membranes, lymph nodes, adrenal glands, and other organs.
  • The fungus exists as a mold in the environment and transforms into a yeast form within human tissues, enabling it to cause disease.

Taxonomy

Classification Details
Kingdom Fungi
Phylum Ascomycota
Order Onygenales
Family Ajellomycetaceae
Genus Paracoccidioides
Species P. brasiliensis, P. lutzii

Habitat and Distribution

Paracoccidioides species are naturally found in:

  • Soil rich in organic matter
  • Agricultural lands
  • Forested regions
  • Humid subtropical and tropical environments

Geographic Distribution

The fungus is endemic in:

  • Brazil
  • Colombia
  • Venezuela
  • Argentina
  • Ecuador
  • Paraguay
  • Peru

Brazil accounts for the majority of reported cases worldwide.

Morphology

Mold Phase (25°C)

  • Grows as filamentous hyphae.
  • Produces conidia that serve as infective particles.
  • Found in soil and environmental sources.

Yeast Phase (37°C)

  • Observed in infected human tissues.
  • Large, thick-walled yeast cells.
  • Characteristic multiple budding pattern.

“Pilot Wheel” Appearance

The most distinctive microscopic feature is the presence of multiple daughter buds surrounding a mother cell, resembling:

  • Pilot wheel
  • Ship’s wheel
  • Mickey Mouse appearance

This feature is considered diagnostic for Paracoccidioides.

Mode of Transmission

Inhalation of Conidia

The primary route of infection involves:

  1. Disturbance of contaminated soil.
  2. Release of fungal conidia into the air.
  3. Inhalation into the respiratory tract.
  4. Conversion of mold to yeast form in lungs.

Risk Factors

  • Agricultural workers
  • Farmers
  • Construction workers
  • Forestry workers
  • Rural residents
  • Smoking
  • Alcohol abuse
  • Immunocompromised individuals

Pathogenesis

After inhalation:

  1. Conidia reach the alveoli.
  2. Transformation into pathogenic yeast form.
  3. Host immune response is activated.
  4. Granuloma formation occurs.
  5. Infection may remain latent for years.
  6. Reactivation can lead to disseminated disease.

Clinical Manifestations

Acute/Subacute Form

Commonly affects:

  • Children
  • Adolescents
  • Young adults

Symptoms include:

  • Fever
  • Weight loss
  • Lymphadenopathy
  • Hepatosplenomegaly
  • Skin lesions

Chronic Form

Most common presentation in adults.

Symptoms:

  • Chronic cough
  • Hemoptysis
  • Dyspnea
  • Chest pain
  • Oral ulcers
  • Mucosal lesions
  • Weight loss

Disseminated Disease

May involve:

  • Skin
  • Lymph nodes
  • Adrenal glands
  • Bones
  • Central nervous system

Laboratory Diagnosis

1. Direct Microscopy

Clinical specimens:

  • Sputum
  • Tissue biopsy
  • Lymph node aspirates

Stains used:

  • KOH preparation
  • Giemsa stain
  • PAS stain
  • Gomori Methenamine Silver (GMS)

Characteristic finding:

  • Multiple budding yeast cells
  • Pilot-wheel appearance

2. Culture

Culture Media:

  • Sabouraud Dextrose Agar (SDA)
  • Brain Heart Infusion Agar (BHI)

Incubation:

  • 25°C for mold phase
  • 37°C for yeast phase

Growth may require several weeks.

3. Histopathology

Important findings:

  • Granulomatous inflammation
  • Giant cells
  • Multiple budding yeast forms

Special stains:

  • PAS
  • GMS

4. Serological Tests

  • Immunodiffusion
  • ELISA
  • Complement fixation

Used for diagnosis and treatment monitoring.

5. Molecular Methods

  • PCR assays
  • DNA sequencing

Provide rapid and accurate identification.

Differential Diagnosis

Paracoccidioidomycosis should be differentiated from:

  • Tuberculosis
  • Histoplasmosis
  • Blastomycosis
  • Coccidioidomycosis
  • Leishmaniasis
  • Squamous cell carcinoma

Treatment

Mild to Moderate Disease

Itraconazole

  • Drug of choice
  • Treatment duration: 6–12 months

Severe Disease

Amphotericin B

  • Used in disseminated or life-threatening infections
  • Followed by oral itraconazole

Alternative Therapy

  • Trimethoprim-Sulfamethoxazole (TMP-SMX)

Prevention

  • Use protective masks during soil-related work.
  • Avoid inhalation of dust in endemic regions.
  • Early diagnosis and treatment.
  • Health education for agricultural workers.

Features of Paracoccidioides

Feature Description
Disease Paracoccidioidomycosis
Type Dimorphic fungus
Transmission Inhalation of conidia
Reservoir Soil
Major Organ Affected Lungs
Diagnostic Feature Pilot-wheel yeast cells
Endemic Area Latin America
Drug of Choice Itraconazole

Scroll to Top
Enable Notifications OK No thanks